Epigral Ltd
Meghmani Finechem Limited (MFL) is part of the Ahmedabad-based Meghmani Group. It was incorporated in September 2007 as a subsidiary of Meghmani Organics Ltd (MOL) but was demerged in April 2021. The company is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives with backward and forward integration facilities and also engaged in trading of Agrochemical products.
- Market Cap ₹ 5,431 Cr.
- Current Price ₹ 1,307
- High / Low ₹ 1,443 / 862
- Stock P/E 27.7
- Book Value ₹ 302
- Dividend Yield 0.38 %
- ROCE 17.0 %
- ROE 16.8 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chlor Alkali / Soda Ash
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
394 | 392 | 598 | 710 | 611 | 829 | 1,551 | 2,188 | 1,929 | |
245 | 248 | 346 | 405 | 416 | 567 | 1,041 | 1,499 | 1,448 | |
Operating Profit | 149 | 144 | 252 | 306 | 194 | 261 | 510 | 689 | 481 |
OPM % | 38% | 37% | 42% | 43% | 32% | 32% | 33% | 31% | 25% |
2 | 1 | 8 | 16 | 2 | 2 | 4 | 8 | 7 | |
Interest | 19 | 14 | 9 | 25 | 11 | 29 | 44 | 66 | 73 |
Depreciation | 44 | 55 | 55 | 54 | 44 | 74 | 86 | 109 | 124 |
Profit before tax | 88 | 75 | 195 | 242 | 141 | 161 | 383 | 523 | 291 |
Tax % | 23% | 11% | 20% | 25% | 21% | 37% | 34% | 32% | 33% |
67 | 67 | 155 | 183 | 112 | 101 | 253 | 353 | 196 | |
EPS in Rs | 9.49 | 9.40 | 21.97 | 44.38 | 27.19 | 24.48 | 60.84 | 85.04 | 47.12 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 6% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 33% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 25% |
TTM: | -45% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 37% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 30% |
3 Years: | 30% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 71 | 71 | 71 | 41 | 42 | 42 | 42 | 42 | 42 |
Reserves | 224 | 291 | 447 | 241 | 331 | 432 | 684 | 1,028 | 1,213 |
Preference Capital | 0 | 0 | 0 | 211 | 211 | 211 | 211 | 110 | |
190 | 123 | 74 | 390 | 526 | 542 | 782 | 769 | 964 | |
55 | 42 | 79 | 373 | 375 | 433 | 616 | 594 | 576 | |
Total Liabilities | 540 | 527 | 671 | 1,044 | 1,273 | 1,449 | 2,124 | 2,432 | 2,794 |
364 | 398 | 347 | 295 | 440 | 1,102 | 1,068 | 1,804 | 1,767 | |
CWIP | 69 | 3 | 79 | 468 | 691 | 126 | 589 | 158 | 483 |
Investments | 0 | 29 | 71 | 0 | 0 | 0 | 0 | 21 | 21 |
106 | 98 | 173 | 281 | 142 | 221 | 467 | 449 | 524 | |
Total Assets | 540 | 527 | 671 | 1,044 | 1,273 | 1,449 | 2,124 | 2,432 | 2,794 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
165 | 229 | 284 | 626 | 398 | |||||
-363 | -197 | -455 | -437 | -401 | |||||
69 | -32 | 195 | -200 | -8 | |||||
Net Cash Flow | -129 | 1 | 24 | -11 | -11 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 43 | 41 | 47 | 40 | 46 | 52 | 60 | 28 | 34 |
Inventory Days | 75 | 59 | 45 | 58 | 64 | 51 | 74 | 69 | 90 |
Days Payable | 31 | 37 | 51 | 52 | 62 | 69 | 42 | 36 | 57 |
Cash Conversion Cycle | 86 | 63 | 42 | 46 | 48 | 34 | 92 | 61 | 67 |
Working Capital Days | 43 | 40 | 19 | -26 | -65 | -59 | 26 | 15 | 25 |
ROCE % | 18% | 37% | 36% | 15% | 16% | 29% | 32% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
11h - Epigral Limited (formerly known as Meghmani Finechem Limited) submits transcript of Conference Call held on 22nd April, 2024 for Q4 FY 24 Results.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - The Company is having One-on-One VC with Axanoun Investment Management on 26.04.2024 and SBICAP Securities Limited on 29.04.2024.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Apr - Epigral Limited (formerly known as Meghmani Finechem Limited) hereby submits Newspaper Publication of Audited Financial Results for quarter and year ended 31.03.2024
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Apr - The Company is having one-on-one meeting with Investor / Analyst on 25.04.2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Apr - The Company is having one-on-one meeting with Investor / Analyst on 24.04.2024
Annual reports
Concalls
-
Apr 2024Transcript PPT
-
Apr 2024TranscriptNotesPPT
-
Jan 2024TranscriptPPT
-
Jan 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT REC
-
Sep 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Apr 2023Transcript PPT REC
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Apr 2022Transcript PPT
-
Apr 2022TranscriptNotesPPT
-
Jan 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
Products:[1]
MFL is the fourth largest manufacturer of Chlor-Alkali and its Derivatives company in India. The company manufactures -
a. Chloralkalis: Caustic Soda Lye and Flakes, Liquid Chlorine, Hydrogen, Caustic Potash Lye and Flakes, etc.
b. Derivatives:The company has Chlor-Alkali Derivatives in the form of Chloromethanes and Hydrogen Peroxide